Showing results (281-290 of 354) with videos related to

Sort By:
Pageof 36
Current Hematologic Malignancy Reports|December 31, 2010
Burkitt lymphoma and atypical Burkitt or Burkitt-like lymphoma: should these be treated as different diseases?Deborah A Thomas, Susan O'Brien, Stefan Faderl, et al.
The Canadian Veterinary Journal = La Revue Veterinaire Canadienne|February 2, 2010
Prevalence of methicillin-resistant Staphylococcus aureus colonization in horses in Saskatchewan, Alberta, and British ColumbiaNathalie Tokateloff, Stephen T Manning, J Scott Weese, et al.
Plos Neglected Tropical Diseases|September 25, 2020
A single mutation (V64G) within the RING Domain of Z attenuates Junin virusSteven J Hallam, John T Manning, Junki Maruyama, et al.
Spine|July 11, 2014
The utility of obtaining routine hematological laboratory values following an anterior cervical diskectomy and fusionBlaine T Manning, Sriram Sankaranarayanan, Hamid Hassanzadeh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1986
Tumor burden assessment and its implication for a prognostic model in advanced diffuse large-cell lymphomaS Jagannath, W S Velasquez, S L Tucker, et al.
Therapeutic Advances in Musculoskeletal Disease|July 28, 2022
The association of depression and anxiety with treatment outcomes in patients with rheumatoid arthritis - a pooled analysis of five randomised controlled trialsArkady T Manning-Bennett, Ashley M Hopkins, Michael J Sorich, et al.
Orthopaedic Journal of Sports Medicine|April 18, 2018
Patient Perspectives of Midlevel Providers in Orthopaedic Sports MedicineBlaine T Manning, Daniel D Bohl, Charles P Hannon, et al.
Bioorganic & Medicinal Chemistry Letters|October 24, 2002
3-Hydroxy-4-methyl-5-pentyl-2-iminopyrrolidine: a potent and highly selective inducible nitric oxide synthase inhibitorSofya Tsymbalov, Timothy J Hagen, William M Moore, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 12, 1994
Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenicJ L Masferrer, B S Zweifel, P T Manning, et al.
Pageof 36